Mrs Soon Kim, MD | |
1516 Virginia Ranch Rd, Gardnerville, NV 89410-5794 | |
(775) 783-3020 | |
(775) 783-3021 |
Full Name | Mrs Soon Kim |
---|---|
Gender | Female |
Speciality | General Surgery |
Experience | 32 Years |
Location | 1516 Virginia Ranch Rd, Gardnerville, Nevada |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649381153 | NPI | - | NPPES |
100502384 | Medicaid | NV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 10696 (Nevada) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mesa View Regional Hospital | Mesquite, NV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mesquite Clinic Management Company Llc | 8123456456 | 19 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
Billions of people using the Earth's resources and changing or destroying ecosystems are not only creating the global environmental and climate crisis, but also compromising human health and long-term survival of our species, experts warn in an open letter to world leaders.
Winner of the Best International Abstract Award, Laura Salgado Lopez, MD, presented her research, A Pilot Study of Deep Brain Stimulation in Treatment-resistant Schizophrenia, during the 2017 American Association of Neurological Surgeons Annual Scientific Meeting.
Luminex Corporation has announced that it has acquired a non-exclusive license from The Johns Hopkins University for the rights to use the university's patented cystic fibrosis genetic markers in the company's molecular diagnostic products sold in the United States.
› Verified 9 days ago
Entity Name | Mesquite Clinic Management Company Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548800501 PECOS PAC ID: 8123456456 Enrollment ID: O20200319000698 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
Billions of people using the Earth's resources and changing or destroying ecosystems are not only creating the global environmental and climate crisis, but also compromising human health and long-term survival of our species, experts warn in an open letter to world leaders.
Winner of the Best International Abstract Award, Laura Salgado Lopez, MD, presented her research, A Pilot Study of Deep Brain Stimulation in Treatment-resistant Schizophrenia, during the 2017 American Association of Neurological Surgeons Annual Scientific Meeting.
Luminex Corporation has announced that it has acquired a non-exclusive license from The Johns Hopkins University for the rights to use the university's patented cystic fibrosis genetic markers in the company's molecular diagnostic products sold in the United States.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Soon Kim, MD 1516 Virginia Ranch Rd, Gardnerville, NV 89410-5794 Ph: (775) 783-3020 | Mrs Soon Kim, MD 1516 Virginia Ranch Rd, Gardnerville, NV 89410-5794 Ph: (775) 783-3020 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
Billions of people using the Earth's resources and changing or destroying ecosystems are not only creating the global environmental and climate crisis, but also compromising human health and long-term survival of our species, experts warn in an open letter to world leaders.
Winner of the Best International Abstract Award, Laura Salgado Lopez, MD, presented her research, A Pilot Study of Deep Brain Stimulation in Treatment-resistant Schizophrenia, during the 2017 American Association of Neurological Surgeons Annual Scientific Meeting.
Luminex Corporation has announced that it has acquired a non-exclusive license from The Johns Hopkins University for the rights to use the university's patented cystic fibrosis genetic markers in the company's molecular diagnostic products sold in the United States.
› Verified 9 days ago